Financial Data and Key Metrics Changes - Q2 revenue increased by 30% year-over-year, reaching $219.4 million, with adjusted operating income growing approximately 13% [8][27] - Adjusted operating margin was approximately 13%, compared to an annual target of 15% [14][31] - Net loss was $13.6 million, or a loss of $0.33 per share, compared to a net loss of $9.2 million, or a loss of $0.23 per share in the prior year [35] Business Line Data and Key Metrics Changes - Subscription revenue was $145.8 million, up 21% year-over-year, with total enrolled subscription pets increasing by 20% to over 770,000 [27][28] - Other business segment revenue was $73.6 million, reflecting a 54% year-over-year increase, with adjusted operating income for this segment at approximately $2 million [32] - Monthly average revenue per pet was $64.26, an increase of 0.9% year-over-year [28] Market Data and Key Metrics Changes - The company added over 61,000 new pets in the quarter, a 10% increase year-over-year [10] - The average invoice size for veterinary services has increased by 8% to 12%, which is approximately double the historical rate of 5% to 6% [12] - The company expects veterinary costs to continue rising by 10% to 15% over the next 3 to 4 years [12] Company Strategy and Development Direction - The company aims to leverage its strong balance sheet to invest in areas with high internal rates of return, focusing on the underpenetrated pet insurance market [9] - Partnerships with veterinarians are emphasized as critical to addressing rising veterinary costs and enhancing service delivery [20][25] - The company is focused on expanding its product offerings and international presence, with new partnerships such as Chewy and Aflac [10][55] Management's Comments on Operating Environment and Future Outlook - Management noted that the current inflationary environment presents unique opportunities for the company, as rising veterinary costs can lead to higher average revenue per user (ARPU) [15][40] - The company is confident in its ability to adjust pricing in response to rising costs while maintaining retention rates [70] - Management expects to achieve adjusted operating income growth of 15% to 20% for the year, with a long-term goal of 25% growth through 2025 [38][78] Other Important Information - The company invested approximately $20 million in acquiring new pets, with a pet acquisition cost of $309 and an estimated 31% internal rate of return [9][33] - Total stock-based compensation expense was $8.5 million, and the company repurchased approximately $5.8 million of its common stock [35][36] - The company ended the quarter with over $243 million in cash and cash equivalents, indicating strong financial health [36] Q&A Session Summary Question: Subscription loss ratio and future targets - Management expects to approach a 71% loss ratio by Q4 2022 through additional cost actions [43] Question: Curbside service in vet clinics - Curbside service is less common now, with increased utilization of the company's software in veterinary clinics [45][46] Question: Trends in deductibles - The company has observed a downward trend in deductibles, contrary to expectations of higher deductibles due to inflation [48] Question: Adjusted operating income guidance - Guidance includes actions across loss adjustment expenses, fixed and variable costs, and pricing actions to achieve targets [51][52] Question: Contribution from new products - Minimal impact is expected from lower-priced products in the second half of the year, while early stages of Chewy and Aflac partnerships show promise [54][55] Question: Software installations and face-to-face interactions - The trend of software installations continues positively, with increased face-to-face interactions with territory partners [57][59] Question: Customer acquisition cost and marketing spend - The internal rate of return for customer acquisition remains strong, with adjustments being made to spending profiles [61][62] Question: ARPU growth and inflation - The company is actively adjusting pricing to keep up with inflation, with ARPU showing modest growth [64][66] Question: Capacity to increase prices without impacting retention - Historical data suggests that retention rates remain stable with moderate price increases, and the company is confident in its pricing strategy [70] Question: Partnership with ezyVet - The partnership provides full integration within the ezyVet platform, enhancing access to veterinary hospitals [71][72] Question: Trends in gross adds and future growth - The company anticipates continued growth driven by veterinary inflation and new distribution channels, despite a potential flattening in gross adds [75][78]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-36537 TRUPANION, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporati ...

Trupanion, Inc. (NASDAQ:TRUP) Q1 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Laura Bainbridge - Investor Relations Darryl Rawlings - Chief Executive Officer Drew Wolff - Chief Financial Officer Margi Tooth - President Tricia Plouf - Chief Operating Officer Conference Call Participants Shweta Khajuria - Evercore ISI Maria Ripps - Canaccord Genuity Elliot Wilbur - Raymond James Josh Shanker - Bank of America Jon Block - Stifel John Barnidge - Piper Sandler Greg Gibas - Northla ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 TRUPANION, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 6100 4th Avenue S, Suite 400 Seattle, Washington 98108 (855) 727 - 9079 (Address, including zip code, and telephone number, including area code, of re ...

March 2022 Trupanion Investor Presentation | --- | --- | |------ ...

Trupanion, Inc. (NASDAQ:TRUP) Q4 2021 Earnings Conference Call February 16, 2022 4:30 PM ET Company Participants Laura Bainbridge - IR Darryl Rawlings - CEO Tricia Plouf - Co-President & COO Drew Wolff - CFO Margi Tooth - Co-President Conference Call Participants John Barnidge - Piper Sandler Shweta Khajuria - Evercore ISI Jonathan Block - Stifel Maria Ripps - Canaccord Ryan Tunis - Autonomous Research Greg Gibas - Northland Securities Operator Greetings and welcome to the Trupanion, Inc. Fourth Quarter 202 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-36537 TRUPANION, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

November 2021 Trupanion Investor Presentation | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------- ...

Trupanion, Inc. (NASDAQ:TRUP) Q3 2021 Earnings Conference Call November 3, 2021 4:30 PM ET Company Participants Laura Bainbridge - IR Darryl Rawlings - CEO Tricia Plouf - Co-President Drew Wolff - CFO Margi Tooth - Co-President Conference Call Participants Maria Ripps - Canaccord Genuity John Barnidge - Piper Sandler Josh Shanker - Bank of America Ryan Tunis - Autonomous Research Jean Lee - Evercore ISI Michael Parolari - Raymond James Greg Gibas - Northland Securities Operator Greetings and welcome to the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-36537 TRUPANION, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...